{{chembox
| verifiedrevid = 462770158
| ImageFile=Buflomedil.svg
| ImageSize=
| IUPACName=4-(pyrrolidin-1-yl)-1-(2,4,6-trimethoxyphenyl)butan-1-one
| OtherNames=
|Section1={{Chembox Identifiers
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = V7I71DQ432
| CASNo_Ref = {{cascite|correct|??}}
| CASNo=55837-25-7 
| PubChem=2467
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 188921
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 2373
| SMILES = O=C(c1c(OC)cc(OC)cc1OC)CCCN2CCCC2
| InChI = 1/C17H25NO4/c1-20-13-11-15(21-2)17(16(12-13)22-3)14(19)7-6-10-18-8-4-5-9-18/h11-12H,4-10H2,1-3H3
| InChIKey = OWYLAEYXIQKAOL-UHFFFAOYAG
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C17H25NO4/c1-20-13-11-15(21-2)17(16(12-13)22-3)14(19)7-6-10-18-8-4-5-9-18/h11-12H,4-10H2,1-3H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = OWYLAEYXIQKAOL-UHFFFAOYSA-N
  }}
|Section2={{Chembox Properties
| Formula=C<sub>17</sub>H<sub>25</sub>NO<sub>4</sub>
| MolarMass=307.38 g/mol
| Appearance=
| Density=
| MeltingPt=
| BoilingPt=
| Solubility=
  }}
|Section6={{Chembox Pharmacology
| ATCCode_prefix = C04
| ATCCode_suffix = AX20
}}
|Section7={{Chembox Hazards
| MainHazards=
| FlashPt=
| AutoignitionPt =
  }}
}} 

'''Buflomedil''' is a [[vasoactive]] drug used to treat [[claudication]] or the symptoms of [[peripheral arterial disease]].  It is currently not approved by the [[Food and Drug Administration]] (FDA) for use in the United States.
Currently available as trade name tablet Loftyl

== Toxicity ==

This drug might be suspended from marketing in the European Union, because of concerns about severe [[neurotoxicity|neurological]] and [[cardiac toxicity]].<ref>Medscape: http://www.medscape.com/viewarticle/753768</ref><ref>EMA: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/public_health_alerts/2011/11/human_pha_detail_000045.jsp&mid=WC0b01ac058001d126</ref> In its press release dated 17 November 2011 EMA suggested that doctors "should stop using buflomedil and consider alternative treatment options".

Various [[adverse effect]]s have been reported to the FDA.<ref>http://www.drugcite.com/?q=BUFLOMEDIL&s=&a=</ref>

== References ==
{{reflist}}

{{Peripheral vasodilators}}

[[Category:Vasodilators]]
[[Category:Pyrrolidines]]
[[Category:Aromatic ketones]]
[[Category:Phenol ethers]]

{{cardiovascular-drug-stub}}